Research

Unbiased Research Methods

Our clients benefit from unbiased research methods via a top-down approach for recommending specific equity investments. Our private clients enjoy regular access to insights from our Equity Research Analyst Leo Carpio. Regularly scheduled conference calls are designed to provide our clients with a comprehensive overview of the financial markets along with independent third party research from leading independent research providers of equity research.

March 17, 2023

4Q22 Results and Update: AIMI and AIMIGo Regulatory Approval Timeline Revised Again. We Affirm Buy and High-Risk Rating, But Lower PT to $6

View Report
March 17, 2023

SKYX Buys Bailey Street Home, a Private Label E-commerce Site, Doubling Down on Go-to-Market Strategy. We Affirm Buy, $8 PT, and Maintain High Risk Rating.

View Report
February 24, 2023

BLIN Reports Modest FY1Q23 Results, a Decent Start to FY2023. Execution Will Be Critical This Year. We Affirm Buy and $4 PT, and High Risk Rating.

View Report

Research
Reports

View Research
Reports
February 9, 2023

SKYX Acquires Belami, Inc., a Specialty eCommerce Vendor, in Move to Accelerate Go-to-Market Strategy. We Affirm Buy and $8 PT, and Maintain High Risk Rating.

View Report
January 11, 2023

CES 2023 Takeaways: 5 Major Trends will Impact Consumer Tech Demand

View Report
December 30, 2022

HeartBeam’s AIMI and AIMIGo Regulatory Approval Timelines Are Pushed Back Into 2023.

View Report